(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 47.36%-1.37M | 37.73%-1.39M | 45.99%-1.56M | 55.58%-9.59M | 35.35%-1.87M | 32.51%-2.59M | 71.90%-2.24M | 58.08%-2.89M | 20.01%-21.59M | 61.67%-2.89M |
Net income from continuing operations | 51.31%-1.09M | -23.23%-2.14M | 34.56%-2.11M | 63.36%-8.31M | 55.33%-1.11M | 56.92%-2.24M | 79.11%-1.74M | 51.78%-3.23M | 22.33%-22.69M | 65.87%-2.48M |
Operating gains losses | -215.27%-216.3K | 139.29%78.09K | 473.49%270.61K | -202.87%-386.65K | -2,138.38%-303.09K | 46.09%187.64K | -182.94%-198.75K | -925.69%-72.46K | 74.15%375.88K | 120.46%14.87K |
Depreciation and amortization | -3.47%64.37K | -8.62%63.85K | -8.52%65.27K | -14.92%274.47K | -10.72%66.56K | -17.42%66.69K | -15.85%69.87K | -15.33%71.35K | 0.82%322.6K | 0.64%74.55K |
Remuneration paid in stock | 11.06%134.46K | -7.58%132.82K | -21.50%377.02K | -35.29%835.41K | -60.47%90.31K | -40.65%121.07K | -37.34%143.72K | -23.65%480.3K | -16.89%1.29M | 21.66%228.49K |
Deferred tax | -190.52%-270.71K | -248.13%-147.07K | -218.46%-207.22K | 401.19%367.56K | 76.14%-205.73K | -70.56%299.07K | -74.61%99.29K | 137.12%174.93K | 118.99%73.34K | -1,217.60%-862.23K |
Other non cashItems | -35.21%244.21K | 207.72%246.26K | -20.74%233.61K | -100.11%-732 | -204.16%-443.81K | 205.01%376.94K | -558.68%-228.61K | 248.29%294.76K | 31.82%684.13K | -16.08%426.08K |
Change In working capital | 83.69%-227.66K | 202.29%380.08K | 69.05%-190.12K | -41.70%-2.33M | 115.99%46.68K | -631.74%-1.4M | 41.83%-371.56K | -16.77%-614.36K | -51,019.24%-1.65M | 67.75%-291.99K |
-Change in receivables | -83.42%17.19K | -438.97%-27.03K | 366.04%51.95K | 209.41%83.15K | 92.60%-9K | -56.91%103.7K | 103.58%7.98K | -170.80%-19.53K | -518.25%-76K | -556.80%-121.56K |
-Change in inventory | -12.77%15.25K | 5.82%-14.15K | 70.55%-7.44K | -139.61%-7.2K | -23.76%15.61K | -18.64%17.48K | -255.66%-15.03K | 24.43%-25.27K | 321.70%18.18K | -22.25%20.48K |
-Change in prepaid assets | -13.41%-139.34K | 7,072.24%192.16K | -86.05%15.84K | -119.23%-54.44K | -132.37%-42.36K | -100.61%-122.86K | -100.50%-2.76K | 133.77%113.53K | 75.01%283.06K | 87.80%130.88K |
-Change in payables and accrued expense | 91.34%-120.76K | 163.33%229.11K | 63.33%-250.47K | -25.81%-2.36M | 125.61%82.42K | -255.91%-1.39M | 62.91%-361.75K | -271.00%-683.1K | -970.57%-1.87M | 0.40%-321.79K |
Tax refund paid | 73.40%-1.93K | ---- | ---- | ---33.14K | ---12.02K | ---7.24K | ---- | ---- | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 47.36%-1.37M | 37.73%-1.39M | 45.99%-1.56M | 55.58%-9.59M | 35.35%-1.87M | 32.51%-2.59M | 71.90%-2.24M | 58.08%-2.89M | 20.01%-21.59M | 61.67%-2.89M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -93.13%86.58K | -85.17%12.99K | -96.66%33.64K | 271.14%2.45M | 255.71%96.55K | 75.14%1.26M | 110.49%87.61K | 180.24%1.01M | 89.05%-1.43M | 99.02%-62.01K |
Net PPE purchase and sale | --0 | --0 | -97.63%21.76K | 165.01%983.63K | 218.99%80K | -99.34%4.65K | 97.89%-18.5K | 172.25%917.48K | 88.97%-1.51M | 98.95%-67.23K |
Interest received (cash flow from investment activities) | -74.36%13.62K | -56.16%12.99K | -86.73%11.89K | 134.37%188.89K | 216.80%16.55K | 171.32%53.14K | -27.62%29.64K | 503.40%89.56K | -87.35%80.6K | -91.35%5.23K |
Net other investing changes | ---- | ---- | ---- | --1.28M | --0 | --1.2M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -93.13%86.58K | -85.17%12.99K | -96.66%33.64K | 271.14%2.45M | 255.71%96.55K | 75.14%1.26M | 110.49%87.61K | 180.24%1.01M | 89.05%-1.43M | 99.02%-62.01K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -33.33%2M | 0.97%1.01M | 0.00%2M | -9.02%6M | 0 | 50.00%3M | -8.91%1M | 302.15%2M | -25.04%6.6M | 1,184.31%3M |
Net issuance payments of debt | -33.33%2M | 0.00%1M | 0.00%2M | 0.00%6M | --0 | 50.00%3M | 0.00%1M | --2M | 22,199.45%6M | 6,666,566.67%3M |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -92.80%635.86K | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -804.11%-40.69K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -33.33%2M | 0.97%1.01M | 0.00%2M | -9.02%6M | --0 | 50.00%3M | -8.91%1M | 302.15%2M | -25.04%6.6M | 1,184.31%3M |
Net cash flow | ||||||||||
Beginning cash position | -1.91%702.14K | -42.29%1.07M | -65.20%606.6K | -90.47%1.74M | 41.00%2.38M | -75.21%715.85K | -82.72%1.86M | -90.47%1.74M | -62.94%18.29M | -94.70%1.69M |
Current changes in cash | -56.72%721.24K | 67.77%-370.59K | 306.83%472.18K | 93.06%-1.14M | -3,887.34%-1.77M | 248.34%1.67M | 85.07%-1.15M | 101.52%116.06K | 47.47%-16.43M | 100.34%46.81K |
Effect of exchange rate changes | 160.09%2.54K | -135.06%-1.52K | -298.03%-4.53K | 103.22%3.58K | -87.88%1.18K | 94.55%-4.22K | 102.34%4.33K | -98.38%2.29K | -148.00%-111.14K | -89.79%9.74K |
End cash Position | -40.04%1.43M | -1.91%702.14K | -42.29%1.07M | -65.20%606.6K | -65.20%606.6K | 41.00%2.38M | -75.21%715.85K | -82.72%1.86M | -90.47%1.74M | -90.47%1.74M |
Free cash from | 47.90%-1.37M | 38.90%-1.39M | 49.53%-1.56M | 58.68%-9.86M | 36.82%-1.87M | 32.98%-2.62M | 74.20%-2.28M | 62.12%-3.09M | 41.36%-23.87M | 78.74%-2.96M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data